Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;12(5):612-22.
doi: 10.1007/s11892-012-0305-4.

Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function

Affiliations
Review

Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function

Nicolynn E Davis et al. Curr Diab Rep. 2012 Oct.

Abstract

Islet cell transplantation has therapeutic potential to cure type 1 diabetes (T1D), which is characterized by autoimmune-mediated destruction of insulin-producing β cells. However, current success rates are limited by long-term decline in islet graft function resulting partially from poor revascularization and immune destruction. Mesenchymal stem cells (MSCs) have the potential to enhance islet transplantation and prevent disease progression by a multifaceted approach. MSCs have been shown to be effective at inhibiting inflammatory-mediated immune responses and at promoting tissue regeneration. The immunomodulatory and tissue repairing properties of MSCs may benefit β cell regeneration in the context of T1D. This review will elucidate how MSCs can minimize β cell damage by providing survival signals and simultaneously modulate the immune response by inhibiting activation, and proliferation of several immune cell types. In addition, MSCs can enhance islet graft revascularization, maintaining long-term β cell viability and function.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Silk hydrogel-based biomaterial
Islets are co-encapsulated in a silk hydrogel with extracellular matrix proteins (ECM) and with bone marrow-derived mesenschymal stem cells (MSC) to enhance islet cell graft revascularization survival and function.

Similar articles

Cited by

References

    1. Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. - PubMed
    1. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Reviews Immunology. 2008;8(9):726–736. - PubMed
    1. Rafei M, et al. Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner. The Journal of Immunology. 2009;182(10):5994–6002. - PubMed
    1. Papadopoulou A, et al. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2012 - PubMed
    1. Choi EW, et al. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue–derived mesenchymal stem cell transplantation. Arthritis & Rheumatism. 2012;64(1):243–253. - PubMed

Publication types

MeSH terms